Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion

NICE technology appraisal guidance [TA229] Published date:

NICE recommends dexamethasone intravitreal implant as a possible treatment for some people with macular oedema due to retinal vein occlusion (see below).

You should be able to have dexamethasone intravitreal implant if:

  • you have macular oedema due to blockage of the central retinal vein, or
  • you have macular oedema due to blockage of a branch retinal vein, and
    • laser treatment has not helped, or
    • laser treatment is not suitable.

NICE looks at how well treatments work, and also at how well they work in relation to how much they cost the NHS. NICE recommended dexamethasone intravitreal implant because it improves vision compared with best supportive care. Although it costs more, this was justified by the benefits provided.

Get involved